ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

FLGT Fulgent Genetics Inc

21.50
0.26 (1.22%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Fulgent Genetics Inc FLGT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.26 1.22% 21.50 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
20.50 20.50 21.60 21.50 21.24
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202406:00BWFulgent Reports First Quarter 2024 Financial Results
11/4/202415:05BWFulgent Genetics to Announce First Quarter 2024 Financial..
05/3/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202418:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202406:08EDGAR2Form 8-K - Current report
28/2/202406:00BWFulgent Reports Fourth Quarter and Full Year 2023 Financial..
27/2/202417:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202417:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202407:00BWFulgent Genetics to Announce Fourth Quarter and Full Year..
09/2/202417:09EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
09/2/202407:31PRNUSCord Blood Registry® (CBR®) by CooperSurgical® and Fulgent..
06/2/202418:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202319:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202320:43EDGAR2Form 144 - Report of proposed sale of securities
06/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202317:13EDGAR2Form 144 - Report of proposed sale of securities
04/12/202317:12EDGAR2Form 144 - Report of proposed sale of securities
20/11/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202320:21EDGAR2Form 144 - Report of proposed sale of securities
14/11/202315:30BWFulgent to Participate in the Piper Sandler 35th Annual..
07/11/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:05BWFulgent Shares Data from Two Poster Presentations at SITC..
03/11/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202306:09EDGAR2Form 8-K - Current report
03/11/202306:00BWFulgent Reports Third Quarter 2023 Financial Results
01/11/202316:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202316:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202316:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202307:00BWFulgent Announces Two Poster Presentations at SITC 2023..
17/10/202307:00BWFulgent Genetics to Announce Third Quarter 2023 Financial..
11/9/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202318:00EDGAR2Form 144 - Report of proposed sale of securities
21/8/202315:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202315:54EDGAR2Form 144 - Report of proposed sale of securities
16/8/202315:51EDGAR2Form 144 - Report of proposed sale of securities
07/8/202316:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202306:07EDGAR2Form 8-K - Current report
04/8/202306:00BWFulgent Reports Second Quarter 2023 Financial Results
03/8/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202315:05GLOBEExagen Inc. Appoints Paul Kim to Board of Directors
18/7/202307:00BWFulgent Genetics to Announce Second Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock